Reducing Complications of Therapeutic Blood Transfusion in Sickle Cell Disease

Click the “View Activity” button to indicate you have reviewed the CME/CE information for this activity.
View Activity

Minimum System Requirements:
  • Internet Explorer 10 (or higher)
  • Mozilla Firefox 48 (or higher)
  • Google Chrome (latest version)
  • Adobe Acrobat 15.0 (or higher)
  • Screen resolution 1024 x 768

This CME/CNE activity is comprised of four chapters:

Credits: 0.5 CME (ACCME); 0.3 CNE (ANCCCA) - Expires: 10/16/2021

Use of blood transfusion during acute illness
Credits: 0.75 CME (ACCME); 0.5 CNE (ANCCCA) - Expires: 10/16/2021

Delayed hemolytic transfusion reactions
Credits: 0.5 CME (ACCME); 0.4 CNE (ANCCCA) - Expires: 10/16/2021 

Management of chronic transfusion
Credits: 0.75 CME (ACCME); 0.5 CNE (ANCCCA) - Expires: 10/16/2021

PROGRAM DESCRIPTION: Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders.  Content is derived from actual peer-reviewed publications.

FEES:  There are no fees charged for CDC’s continuing education activities.

Jointly provided by the Centers for Disease Control & Prevention, Georgia State University & Emory University School of Medicine

“Reducing Complications of Therapeutic Blood Transfusion in Sickle Cell Disease” is a free CME/CNE accredited, 4-part, web-on-demand educational series, developed via a cooperative agreement between the Centers for Disease Control and Prevention and Georgia State University. The program, which features Sickle Cell Disease experts James Eckman MD, Peter Lane MD, and Ross Fasano MD, includes case-based examples to explain the most recent, evidence-based practice recommendations. The Blood CME Center™ is assisting the CDC and Georgia State University in bringing awareness to these activities, but does not have any responsibility for content or certificate issuance. Please click on: for more information.